文献速递胸部CT

改良 Lung-RADS 在非吸烟相关肺癌高发人群中提高筛查低剂量 CT 性能

Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
PubMed 文献 · Acad Radiol · 2018-03-09

回顾性分析 1978 例连续健康受试者(72.8% 非吸烟者)的低剂量 CT 筛查数据,将 Lung-RADS 2 类和 3 类细分为 2A/2B/2C 和 3A/3B/3C 亚类。改良 Lung-RADS 以 2C 为 cutoff 预测腺癌谱病变的 AUC 为 0.973(敏感度 100%,特异度 89.3%),显著高于 Lung-RADS(AUC=0.815,P<.001)和 NLST 标准(AUC=0.906,P<.001)。

要点

  • 改良 Lung-RADS 以 2C 为 cutoff 预测腺癌谱病变的 AUC 为 0.973,敏感度 100%,特异度 89.3%。
  • 以 3B 为 cutoff 预测浸润性腺癌的 AUC 为 0.992,敏感度 95%,特异度 97.8%。
  • 改良 Lung-RADS 对部分实性结节的细分可能提高鉴别浸润性与惰性腺癌的能力。

核心结论

  • 在腺癌高发的亚洲人群中,改良 Lung-RADS 可能大幅提高检测腺癌谱病变的敏感度,同时保持特异度,并通过 2C 和 3B 两个 cutoff 值对部分实性结节进行更精细分类,增强鉴别浸润性与惰性腺癌的能力。

研究设计与样本

  • 回顾性队列研究,纳入 2013 年 8 月至 2014 年 10 月期间接受低剂量 CT 的 1978 例连续健康受试者(1084 名男性,894 名女性;72.8% 为非吸烟者),将 Lung-RADS 2 类和 3 类分别修改为包含 2A/2B/2C 和 3A/3B/3C 亚类,随访期间(1.6 ± 0.5 年)以病理证实的腺癌谱病变为参考标准。

诊断标准与关键数值

  • 改良 Lung-RADS 以 2C 为 cutoff 预测腺癌谱病变:AUC 0.973,敏感度 100%,特异度 89.3%。
  • Lung-RADS 预测腺癌谱病变:AUC 0.815,与改良 Lung-RADS 相比 P<.001。
  • NLST 标准预测腺癌谱病变:AUC 0.906,与改良 Lung-RADS 相比 P<.001。
  • 改良 Lung-RADS 以 3B 为 cutoff 预测浸润性腺癌:AUC 0.992,敏感度 95%,特异度 97.8%。

临床应用与阅片要点

  • 作者认为改良 Lung-RADS 可能提高腺癌谱病变检测的敏感度并保持特异度。
  • 作者指出改良 Lung-RADS 通过 2C 和 3B 两个 cutoff 值对部分实性结节细分,可能增强鉴别浸润性与惰性腺癌的能力。
  • 作者认为改良 Lung-RADS 在临床实践中的效果必须在前瞻性大型队列研究中仔细研究。

局限性

  • 原文结论指出改良 Lung-RADS 在临床实践中的效果必须在前瞻性大型队列研究中仔细研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We proposed a modification of the ACR Lung Imaging Reporting and Data System (Lung-RADS) to clarify the characteristics of subsolid nodules with categories 1-11, and to compare the diagnostic accuracy with Lung-RADS and National Lung Screening Trial criteria in an Asian population with high prevalence of adenocarcinoma.

METHODS: We analyzed a retrospective cohort of 1978 consecutive healthy subjects (72.8% nonsmoker) who underwent low-dose computed tomography from August 2013 to October 2014 (1084 men, 894 women). Lung-RADS categories 2 and 3 were modified to include subcategories of 2A/2B/2C and 3A/3B/3C, respectively. Clinical information and nodule characteristics were recorded. Receiver operating characteristic curves were used to compare diagnostic accuracy at different cutoffs.

RESULTS: Thirty-two subjects (30 nonsmokers) had pathology-proven adenocarcinoma spectrum lesions in the follow-up period (1.6 ± 0.5 years). Modified Lung-RADS, using modified Lung-RADS category 2C as cutoff, had an area under the curve (AUC) of 0.973 in predicting adenocarcinoma spectrum lesions (sensitivity of 100%, specificity of 89.3%), which was significantly higher than that of Lung-RADS (AUC = 0.815, P < .001) and National Lung Screening Trial (AUC = 0.906, P < .001). Furthermore, modified Lung-RADS showed an AUC of 0.992 in predicting invasive adenocarcinoma (sensitivity of 95%, specificity of 97.8%) when category 3B was used as cutoff.

CONCLUSIONS: Modified Lung-RADS may substantially improve sensitivity while maintaining specificity for detection of adenocarcinoma spectrum lesions in an Asian population. Compared to Lung-RADS, it has enhanced ability to differentiate invasive from indolent adenocarcinoma by more refined subclassification of subsolid nodules using two cutoff values of category 2C and 3B. The effect of using modified Lung-RADS in clinical practice must be carefully studied in prospective large cohort studies.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Hsu HT, Tang EK, Wu MT, et al. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer. Acad Radiol. 2018. PMID: 29530488. doi:10.1016/j.acra.2018.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。